http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Thu, 21 May 2026 08:33:10 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Corporate+News/Nexalin+Technology+gains+House+support+for+VA+neurostimulation+research/26532025.html <p>Nexalin Technology Inc. (NASDAQ: NXL) announced that the U.S. House of Representatives passed appropriations bill language directing the Department of Veterans Affairs to support additional research into non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury.</p><p>The House passed the Fiscal Year 2027 Military Construction, Veterans Affairs, and Related Agencies Appropriations bill in a 400-15 vote. The accompanying report language encourages the VA to evaluate the safety, efficacy, and clinical applications of non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant TBI.</p><p>The bill includes $945 million for VA Medical Research. The neurostimulation directive was among a limited number http://www.streetinsider.com/Corporate+News/Nexalin+Technology+gains+House+support+for+VA+neurostimulation+research/26532025.html Thu, 21 May 2026 08:33:10 -0400 NXL http://www.streetinsider.com/Corporate+News/Nexalin+Technology+secures+neurostimulation+research+language+in+House+bill/26532003.html <p>Nexalin Technology Inc. (NASDAQ: NXL) announced that language it advocated for was included in a U.S. House appropriations bill directing the Department of Veterans Affairs to research non-invasive deep brain neurostimulation technologies for traumatic brain injury treatment.</p><p>The House of Representatives passed the Fiscal Year 2027 Military Construction, Veterans Affairs, and Related Agencies Appropriations bill in a 400-15 vote. The accompanying report language encourages the VA to "support additional research evaluating the safety, efficacy, and potential clinical applications" of non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury.</p><p>The bill includes $945 million for VA Medical Research. The neurostimulation http://www.streetinsider.com/Corporate+News/Nexalin+Technology+secures+neurostimulation+research+language+in+House+bill/26532003.html Thu, 21 May 2026 08:31:20 -0400 NXL http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+Vete/26531922.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+Vete/26531922.html Thu, 21 May 2026 08:30:00 -0400 NXL http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+Vete/26531922.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+Vete/26531922.html Thu, 21 May 2026 08:30:00 -0400 NXL http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Press+Releases/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html <p align="center">U.S. House Appropriations Committee report language directs VA to support additional research evaluating non-invasive deep brain neurostimulation technologies for veterans with treatment-resistant traumatic brain injury</p> <p align="center">Report language, championed through the Nexalin America division, builds on Nexalin’s ongoing UC San Diego / San Diego VA-related TBI clinical research program</p> <p align="center">Marks second Congressional action this year referencing non-invasive deep brain neurostimulation as an emerging therapy for veterans</p> <p align="left">HOUSTON, TX, May 21, 2026 (GLOBE NEWSWIRE) -- <b>Nexalin Technology, Inc. (Nasdaq: NXL)</b> (the “Company” or “Nexalin”), the leader in non-invasive Deep Intracranial Frequency Stimulation (DIFS™) http://www.streetinsider.com/Globe+Newswire/Nexalin+Technology+Secures+Key+Neurostimulation+Legislative+Provision+%26amp%3B+Commends+U.S.+House-Passed+Report+Language+Expanding+Non-Invasive+Deep+Brain+Neurostimulation+Research+at+the+Department+of+/26531977.html Thu, 21 May 2026 08:30:00 -0400 A.00549027 A.06822034 A.19651963 NXL NXLIW O.03308283 O.20026344 O.21314198 O.41318195 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexalin+Technology%2C+Inc.++For%3A+May+14/26520845.html si-local-file:///var/storage/secattach/20260519/26520845.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexalin+Technology%2C+Inc.++For%3A+May+14/26520845.html Tue, 19 May 2026 16:00:00 -0400 NXL O.41318195 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexalin+Technology%2C+Inc.++For%3A+May+14/26520845.html si-local-file:///var/storage/secattach/20260519/26520845.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Nexalin+Technology%2C+Inc.++For%3A+May+14/26520845.html Tue, 19 May 2026 16:00:00 -0400 NXL O.41318195 http://www.streetinsider.com/Mergers+and+Acquisitions/Nexalin+acquires+digital+health+platform+for+%241.3+million+ahead+of+trial/26517929.html <p>Nexalin Technology Inc. (NASDAQ: NXL) completed its acquisition of PONM Inc., a digital health platform that supports the company's HALO Clarity program and Nexalin NeuroCare virtual clinic, according to a press release.</p> <p>The Houston-based neurostimulation company acquired PONM from GreenLight Ventures LLC for $1.3 million, payable in Nexalin common stock issued over time at prices tied to the company's market performance. Through the transaction, Nexalin gained ownership of PONM and an exclusive license to proprietary software features including AI-integrated remote patient monitoring, treatment-compliance data capture, and electronic health record functionality.</p> <p>The platform is deployed at the University of California, San Diego, where http://www.streetinsider.com/Mergers+and+Acquisitions/Nexalin+acquires+digital+health+platform+for+%241.3+million+ahead+of+trial/26517929.html Tue, 19 May 2026 08:30:25 -0400 A.06822034 A.19651963 A.38047855 NXL NXLIW O.19984120 O.20026344 O.21314198 O.41318195